Las Vegas, NV -- (SBWIRE) -- 12/05/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: EMC Corporation (NYSE:EMC), Trina Solar Limited (ADR) (NYSE:TSL), Cell Therapeutics Inc (NASDAQ:CTIC), Growlife Inc (OTCBB:PHOT).
EMC Corporation (NYSE:EMC) ended its recent business day with the advanced of 0.93% and closed at the price of $23.82 after opening at $23.60. The stock traded during its last trading session with the total volume of 24.56 million shares, as compared to its average volume of 22.10 million shares. EMC Corporation, together with its subsidiaries, develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services.
Will EMC Continue To Move Higher? Find Out Here
Trina Solar Limited (ADR) (NYSE:TSL) remained among the day bullish 3.15% and traded with volume of 3.61 million shares in the last session, as compared to average volume of 5.95 million shares. In comparison with 52 week range of $2.70 - $17.84, it faced lowest price of $13.75 during the last trading session whereas its day highest price was $14.58. The company’s total market capitalization is $1.15 billion, along with 79.87 million shares outstanding. Trina Solar Limited, an integrated solar-power products manufacturer, engages in the design, development, manufacture, and sale of photovoltaic (PV) modules worldwide. The company provides mono- and multi-crystalline silicon ingots, wafers, cells, and related products.
Will TSL Continue To Move Higher? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) showed 1.47 million shares in volume during the last trading session, while the average trading volume remained 3.37 million shares. The stock kicked off its trading session at $1.98 and closed at $1.95 after rallied 2.09%. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Will CTIC Continue To Move Higher? Find Out Here
Growlife Inc (OTCBB:PHOT) stock traded during its last trading session with the total traded volume of 3.22 million shares versus its average volume of 14.69 million shares. The company opened its trade at the price of $0.09 and its closing price was $0.0895 after gained 1.70% for the day. Growlife, Inc., through its subsidiaries, manufactures and markets horticulture and lifestyle products in the United States and internationally.
Will PHOT Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)